Study of Hepatitis C Treatment During Pregnancy

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

February 3, 2020

Study Completion Date

February 3, 2020

Conditions
Hepatitis CPregnancy
Interventions
DRUG

ledipasvir/sofosbuvir

Hepatitis C treatment with ledipasvir and sofosbuvir will be initiated during pregnancy at approximately 24 weeks of gestation.

Trial Locations (1)

15213

Magee Womens Hospital, Pittsburgh

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

collaborator

University of Nebraska

OTHER

lead

Catherine Chappell

OTHER